Time to Be Launched 1 auXiliary Risk strat1fier in marginal zone lymphoma transformation: TBL1XR1

Cancer. 2024 Apr 15;130(8):1204-1207. doi: 10.1002/cncr.35246. Epub 2024 Feb 14.

Authors

Alexandar Tzankov¹, Maciej Tatarczuch²

Affiliations

¹ Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
² Monash Hematology and Blood Cancer Therapeutics Laboratory, Department of Medicine, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.

PMID: 38353491
DOI: 10.1002/cncr.35246

No abstract available

Keywords: TBL1XR1; genomics; high-grade transformation; marginal zone lymphoma.

Publication types

Editorial

MeSH terms

Humans
Lymphoma, B-Cell, Marginal Zone*
Receptors, Cytoplasmic and Nuclear / genetics
Repressor Proteins / genetics

Substances

TBL1XR1 protein, human
Repressor Proteins
Receptors, Cytoplasmic and Nuclear